Why Invest in the Southeast? In sum, because the region’s dynamic and growing economy produces strong deal flow at reasonable valuations, and has historically produced higher returns for venture investors than other regions of the country. The Southeastern economy...Read More
RICHMOND, VA. – ImmunArray, a company based in the Virginia Biotechnology Research Park in Richmond, has received a $10 million investment that will help it further develop its blood-testing technology for chronic diseases such as lupus and for traumatic head injuries.read more
Early Bird Registration is open until July 29th!! Save $100 by registering now!
The flow of the meeting is different this year, so check out the agenda to see how things are coming along.
Looking forward to seeing everyone there!read more
Arbor Pharmaceuticals, LLC and XenoPort, Inc. announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03 per share in cash, or a total equity value of approximately $467 million.read more